Article
Transcriptomic Deconvolution Reveals Prognostic Immune Signatures and Immunotherapy-Responsive Subtypes in Male Breast Cancer
2025-10-27
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Male breast cancer (MBC) is a rare malignancy with distinct biological and clinical features compared to its female counterpart. Emerging evidence suggests that a subset of MBCs may exhibit an immunogenic tumor microenvironment; however, the lack of sex-specific data on immune biomarkers has limited the inclusion of male patients in immunotherapy trials. <bo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f0e27345-38ed-544c-9431-60c31e9a8bc0
- DOI
- 10.21203/rs.3.rs-7572724/v1
